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To my beloved  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Would it not be strange if a universe without purpose accidentally  
created humans who are so obsessed with purpose?  
 
Sir John Templeton
 ABSTRACT 
Enzymes are indispensable in maintaining the biological system. They metabolize 
complex molecules to supply nutrients, to produce energy, to regulate transcription of 
gene expression, and to control the concentration of effective signaling molecules in a 
cell, thus maintaining the homeostasis of biological system. This thesis summarizes the 
study of the structure and function of two enzymes in lipid signaling family using 
integrative application of X-ray crystallography, solution NMR spectroscopy, light 
scattering, ITC and thermal shift assay.  
Lipocalin prostaglandin D synthase (L-PGDS) is a tissue specific prostaglandin D2 
producing enzyme with a lipocalin fold. Apart from its enzymatic role, it is known to 
act as a lipophilic ligand carrier. Crystal structure of human L-PGDS and substrate 
analog altogether with NMR spectroscopy experiments revealed binding sites for 
substrate catalysis and entry. NMR titration experiments with membrane mimetic 
showed that L-PGDS has intrinsic membrane binding affinity depending on the ligand 
bound. These results allowed a model of substrate catalysis and product egression to be 
proposed, hence, converging the enzymatic and transporter role that has been reported 
in literature previously. Since prostaglandin D2 is a pivotal inflammatory signaling 
molecule, molecular understanding of L-PGDS is important to facilitate future 
regulation of the prostaglandin isomerase. The dynamics of substrate-product exchange 
may guide future design of this lipophilic carrier as vehicle for drug delivery.  
The second enzyme, human acid sphingomyelinase like 3a (SMPDL3a), belongs to a 
metallophosphodiesterase family and shares close sequence identity with human acid 
sphingomyelinase (aSMase). SMPDL3a’s structure is reported for the first time 
revealing its binuclear catalytic core site bound with Zn metal. Even though it was 
presumed to be part of the lipid hydrolase family, enzymatic assays showed that it 
metabolizes nucleotides and modified nucleotides like CDP-choline, CDP-
ethanolamine and ADP-ribose. Subsequently, CDP-choline soaked crystal revealed 5’ 
cytidine monophosphate (CMP) ligand bound in the catalytic site due to spontaneous 
catalysis. Its -phosphate forms key interactions with histidine residues in the binuclear 
center. Based on this CMP-enzyme structure, general catalytic mechanism of aSMase 
family can be proposed. Besides, SMPDL3a also serves as a template for aSMase 
catalytic domain homology modeling. Further study on enzymes in the acid 
sphingomyelinase family can now be guided by the newly available structural 
information.  
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1 ENZYMES – CATALYSTS OF THE CHEMISTRY OF LIFE 
In the mid-18th century, scientists began to observe that saliva is able to breakdown starch [1], 
and almost a few decades later, Payen and Persoz discovered and isolated the starch-
decomposing compound which they called “diatase”, now commonly known as amylase [2]. 
Twenty years after the release of Payen’s discovery, Louis Pasteur proposed that a “vital 
force” in yeast promotes fermentation of sugar to alcohol in 1858 [3] and Wilhem Kühne 
used the word “enzyme” to describe the process of fermentation. It was subsequently used to 
refer to the protein that catalyzes the biochemistry reaction. In fact, the term  “catalyst” was 
coined by Swedish chemist, Jöns Jakob Berzelius in 1835 based on work from other scientists 
whom he collected and observed. An excerpt of his published statement:  
 
“It is then shown that several simple and compound bodies, soluble and insoluble, have the 
property of exercising on other bodies and action very different from chemical affinity. The 
body effecting the changes does not take part in the reaction and remains unaltered through 
the reaction.” – [4] 
 
This sets the fundamental foundation for the concept of catalysis. Now, we understand that a 
catalyst acts to speed up a chemical reaction by lowering its activation energy while 
remaining unchanged at the end of the reaction (Figure 1). This energy barrier is important to 
prevent chemical reactions from occurring spontaneously. However, if unaided, most 
chemical reactions would occur very slowly due to the high activation energy required. 
Therefore the presence of a catalyst is vital to increase the speed of reactions and allows only 
certain reaction to take place at a time. These controlled-chemical processes in a biological 
system are normally governed by enzymes.  
At the end of 19th century, many scientists began to draw great interest in the study of 
enzymes and this have contributed significantly in shaping the current understanding of 
enzymology and cellular processes where they are involved. Buchner was the first to describe 
enzymatic reaction outside of living cells and he was awarded the Nobel prize in Chemistry 
for his discovery of cell-free fermentation [5]. This enabled the application of cell free 
enzyme systems in food and wine processing during the 20th century.  
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Around 1890s, scientists began to study the reaction rate of enzymatic induced biochemical 
reaction when they realize that enzymatic reaction can be observed outside of the living cells. 
Many deduced that enzyme performs its reaction by forming complex with its substrate and a 
chemist, Emil Fischer, proposed a lock and key model to explain the enzyme-substrate 
interaction [6]. Subsequently L. Michaelis and M. Menten proposed the basic idea of 
enzymatic reaction in the following reaction scheme. 
퐸 푆 푘 퐸푆 푘 퐸 푃 
For a single transition state, the reaction would result in forming the first intermediate (ES) 
before proceeding to yield the product (P). The rate of constant k1 described the binding of 
substrate to enzyme whereas the k2 described the catalytic rate of reaction turning from 
substrate to product. The process can also be reversed with rate constant k-1. When a reaction 
reaches steady state, the ES intermediate concentration is assumed to be relatively constant 
where the rate of ES formation is close to or same as the rate of ES dissociation. This steady 
state approximation allows derivation of the Michaelis-Menten equation [7].  
푉  
휈푚푎푥 푆
퐾푀  푆
 
The Michaelis-Menten equation explains kinetics of enzymatic reaction. From the equation, 
the reaction rate dependence on substrate and enzyme concentration can be explained. For 
example, a low KM value indicates a strong binding between substrate and enzyme in which 
small amount of substrate concentration result in 50% of maximum reaction velocity. 
Enzyme kinetics enables scientists to make important observations such as measuring the 
change of reaction rate with respect to change of pH and temperature. This pH and 
temperature dependence is attributed to the protein nature of enzyme but the identity of 
 
Figure 1: Energy barrier of chemical reactions (also termed activation energy) is lowered in the presence of 
enzyme. 
k-1 
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enzyme was still unknown at that time. It was not until 1926 when J. B. Sumner showed that 
the enzyme urease is a protein and it can be isolated and crystallized. Despite confronted with 
much skepticism, his findings were soon confirmed by J. H. Northrop and W.M. Stanley [8-
11].  
It is now well established that enzymes are versatile catalysts that can have exquisite 
selectivity. They facilitate most chemical reactions in biological system including processes 
controlling gene expression, signal transduction, energy production, molecular motors and 
cellular homeostasis. The enzyme’s function can be assisted by catalytic cofactors such as 
prosthetic group, metal ions and co-enzyme, or further regulated by posttranslational 
modifications, interacting proteins or allosteric modulation. Most enzymes are proteins but 
many proteins are not enzymes. Proteins have three-dimensional structures comprising a 
chain of amino acids connected by peptide bonds. Apart from proteins, RNA has also being 
identified with enzymatic ability [12]. Nonetheless, this thesis will focus only on protein 
enzymes.  
1.1 ENZYME STRUCTURE AND FUNCTION 
Sumner’s urease extraction and crystallization work did not just provided a breakthrough in 
the understanding of enzymes but it also set the stage for much later work in the field of 
structural biology. From 1912 to 1930s, there were many small chemical structures being 
determined using X-ray crystallography. The physical method was introduced into the 
biological world when Crowfoot, D. first demonstrated that protein crystals showed distinct 
X-ray diffraction patterns like chemical crystals [13]. Based on fiber diffraction method, J. 
Watson, F. Crick and R. Franklin first uncovered the structure of DNA nucleic acid [14]. It 
was an extraordinary breakthrough and an important step towards the formulation of the 
central dogma of molecular biology that explains the flow of information from DNA to 
mRNA and subsequently translated to proteins. The excitement of viewing DNA structure 
spurred scientist like M. Perutz and J.C. Kendrew to work towards the first protein structure – 
myoglobin in just five years later [15]. It was soon followed by the first enzyme structure, the 
hen egg white lysozyme, in 1965 [16, 17].  
Structural elucidations of enzymes have contributed significantly in establishing the 
principles of enzyme function. The emergence of serine proteases structures including 
trypsin, pepsin, chymotrypsin and papain gave early insights into the structural basis for 
catalysis and substrate specificity of these enzymes [18, 19]. Following the structural 
information explosion, especially in the last 20 years, the field now provides a comprehensive 
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view of many important biological systems on the structural level, including enzyme 
functionalities. Since many drug targets are enzymes, these structural information, and 
accompanying strategies to rapidly determine protein structure, now serve as a valuable 
source to guide rational drug design.   
1.2 THE LINE BETWEEN SPECIFICITY AND PROMISCUITY 
Enzyme has an active site where the substrate is bound and chemical reaction takes place. 
Fischer’s lock and key model in 1894 proposed that the substrate has to be perfectly 
complimentary to the active site for productive interactions [6]. In this model, the specificity 
of enzyme is governed by the fact that geometrically incompatible substrate would not be the 
right ‘key’ to activate the ‘lock’ (enzyme) (Figure 2A). In 1958 D.E. Koshland suggested a 
modification of the prevailing model to the ‘induced-fit model’ based on his study on 
hexokinase [20]. In the ‘induced-fit model’, both the enzyme and substrate were deemed to 
be moderately flexible and the encounter of enzyme-substrate in the correct orientation would 
induce conformational change in the active site to promote catalysis (Figure 2B). Scientists 
gradually disfavor the ‘lock-and-key’ model when more and more enzyme structures with 
and without their substrate(s) have been unveiled. These atomic resolution structures showed 
that enzymes in their substrate-bound and unbound states could adopt different 
conformations.  
The enzyme substrate interactions are often quite specific in order to tightly control the in 
vivo chemical transformations.  As a result, enzymes are generally classified by the types of 
chemical transformation they catalyze which usually include a defined substrate. However, 
there are also many enzymes which have a relatively broad substrate specificity such as 
pyruvate decarboxylase [21], pepsin [22] and chymotrypsin [23].The phenomenon where 
enzyme catalyzes substrate other than the substrate it physiologically specialized is termed 
substrate promiscuity [24, 25]. Substrate promiscuity can be achieved by for example 
structural plasticity at the active site where it could adopt alternate conformations [26, 27].  
The molecular level of specificity can also be regulated by gene expression, 
compartmentalization and allosteric modification to impart specificity of action at the system 
level. For example, many enzymes are not constitutively expressed or always in the active 
form, instead of protein level, localization and activity of enzyme can be controlled by 
cellular or external stimulation. Even if a promiscuous enzyme was expressed constitutively, 
its cellular localization, activation by effectors and availability of substrates set boundaries for 
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its enzymatic action. Nonetheless, most enzymes are still highly specific and efficient in their 
role.  
 
1.3 ENZYMES IN METABOLIC PATHWAYS 
Enzymes, given the above-discussed nature and modus operandi, are indispensible and 
paramount in all types pathways and processes in biological systems. A series of enzymes 
can be localized to catalyze stepwise biochemical reactions that are more or less 
interdependent of one another. The arachidonic acid metabolism pathway is one such 
example. The initial substrate phospholipid is converted to an arachidonic acid (AA) as the 
first committed step in the pathway. The long hydrocarbon chain of AA can be further 
oxygenated via three specific enzymes into three distinct signaling pathways. Therefore 
metabolism of arachidonic acids generates a class of lipid signaling molecules known as 
eicosanoids. Eicosanoids signaling is further elaborated in Chapter 4 in the study of enzyme 
lipocalin prostaglandin D synthase (L-PGDS). 
The second enzyme in our study is a homolog of the lipid modifying enzyme, acid 
sphingomyelinase (aSMase), that is involved in ceramide metabolism. Ceramide belongs to a 
class of lipids known as sphingolipids, which carries a sphingoid backbone and it can be 
produced via three pathways; de novo synthesis from palmitate [28] and serine, salvage 
pathway from recycled sphingosines [29] or breakdown of sphingomyelin [30]. Enzyme 
ASMase produces ceramide by breaking the phosphodiester bond of sphingomyelin. 
However, our studies and other literature reports found that the conserved catalytic domain of 
the acid sphingomyelinase like 3a (SMPDL3a) enzyme selects nucleotide substrate instead of 
sphingomyelin [31]. This is a classical example of enzymes with conserved structural 
domains but with modified substrate pocket for substrate specificity. From an evolutionary 
point of view, this is efficient way to develop specialization. Nonetheless, the exact 
 
Figure 2. Cartoon depiction of Fischer’s lock and key model in (A) versus Koshland’s Induced-fit model in 
(B) 
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physiological substrate and biological function of SMPDL3a is unfortunately still unclear. 
The work in Paper II helps to establish a structural and biochemical framework for future 
study of this protein and the definition of it´s biological role.  
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2 AIM OF THESIS 
A total of 110,789 protein, DNA and RNA structures were deposited in the Protein Data 
Bank (www.rcsb.org) as of August 2015. Among those, 98720 were solved with X-ray 
crystallography, 11077 by nuclear magnetic resonance (NMR) spectroscopy, and 809 by 
cryo-electron microscopy (cryo-EM) [32]. This exponential growth of structures is fueled by 
innovative techniques at different stages of the structure elucidation process and high-
throughput automation. X-ray crystallography celebrated its 100 years anniversary in 2014 
and is still the dominating method in structure biology. Most importantly, together with X-ray 
crystallography, other structural methods such as NMR, high-resolution cryo-EM and small-
angle X-ray scattering (SAXS) can be used in parallel to address a specific structural 
problem. This idea of integrative structural biology is slowly gaining ground as well as 
further integrating biophysical, biochemical analysis, cellular studies, bioinformatics and 
computations biology to give a more holistic view of protein’s function and mechanism.  
The aim of this thesis is to gain structural and functional insights into two important lipid 
enzyme families in human cells by integrating several techniques including X-ray 
crystallography and solution NMR spectroscopy as well as biophysical binding studies and 
biochemical activity assays. 
Paper I 
Human lipocalin Prostaglandin D synthase (L-PGDS) has previously been in the spotlight for 
structural study using X-ray crystallography, NMR spectroscopy and SAXS individually. 
Despite several mouse L-PGDS structures being reported, these structures usually harbor a 
catalytic residue mutation with an empty substrate binding pocket and unclear the structural 
basis of the enzyme and transporter activities. Therefore the objective of this project was to 
uncover the molecular mechanism of substrate binding, catalysis and product release of wild 
type L-PGDS utilizing a combination of X-ray crystallography and NMR.  
Paper II 
Sphingomyelin phosphodiesterase like 3a (SMPDL3a) has been proposed to share similar 
function with its close homolog acid sphingomyelinase (aSMase), based on the conservation 
of its metallophosphodiesterase domain. Apart from that, little is known about this protein 
except its regulation by liver X receptor, cAMP activation and cholesterol loading on 
macrophages as well as absence of sphingomyelinase activity. This project aims to shed light 
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on the structure, function and mechanism of SMPDL3a, with possible implications for an 
understanding of the aSMase family. 
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3 FROM PROTEIN TO STRUCTURE AND FUNCTION 
3.1 RECOMBINANT PROTEIN EXPRESSION  
In order to obtain large amount of highly pure and homogenous proteins for structural studies, 
recombinant protein over-expression is most often an essential requirement. Proteins can be 
over-expressed in either a cell-based system or a cell free system but currently cell-based 
expression is still most commonly used. Two types of cell-based systems were used in this 
work and they will be discussed further in the following sections.  
3.1.1 Bacterial expression systems 
The bacterial system is the oldest and most widely used cell-based system for recombinant 
protein expression due to its efficiency, simplicity and economical attributes. Prokaryotic 
cells have simpler transcription-translation machinery and a fast growth rate . It is genetically 
easy to manipulate and quick to obtain large cell mass containing proteins of interest. The 
target gene is cloned into bacteria expression vectors and subsequently the plasmid is 
transformed into bacteria cells for amplification. Under antibiotic selection pressure specific 
to the recombinant plasmid, only bacteria cells with the target gene is multiplied and 
subsequently induced to express the heterologous gene. The bacteria system can be used to 
also express various types of isotope labeled proteins for NMR experiments.  
3.1.1.1 L-PGDS recombinant protein expression 
In Paper I, the human lipocalin prostaglandin D synthase cDNA was cloned into pNIC-CH3 
vector containing a C-terminal non-cleavable hexa-His tag [33]. Escherichia coli (E.coli) of 
BL21 (DE3) Rosetta T1R strain was transformed with the vector containing the gene of 
interest, then cultured in Terrific-broth (TB) media. The production of L-PGDS was induced 
using isopropyl-1-thio--D-galactopyranoside (IPTG) and harvested after 16-hours growth at 
37°C. 
Isotope-labeled proteins for NMR studies were expressed similarly in M9 minimal media 
supplemented with 15N-labelled ammonium chloride (HN4Cl) for single labeled protein. 
Doubled labeled protein was expressed with both 15N-HN4Cl and 13C-labeled glucose added. 
The M9 media was also supplemented with 15N-HN4Cl and 13C-labelled leucine and alanine 
to label the respective residue type in a non-deuterated environment.  
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3.1.2 Insect cells system 
Another increasingly popular cell-based system is the binary baculovirus-insect cells system. 
Baculovirus is referred to a family of virus with large, circular double stranded DNA that has 
a rather specific host range. It is known to infect primarily anthropods like insects [34]. Years 
of development have led to a more optimized Baculovirus genome for recombinant 
expression of foreign protein in insect cells. A commercially available Bac-to-Bac method 
based on Luckow et al’s paper is adopted in our production of human acid sphingomyelinase 
like protein (SMPDL3a) in Paper II [35].  
This system employs a baculovirus shuttle vector known as bacmid. The gene of interest is 
first cloned into a vector and transformed into DH10Bac competent cells that carry a bacmid 
with transposition insertion site (attTn7) and a transposition helper plasmid. This allows the 
transposition of gene of interest from the vector to the bacmid which disrupts the lacZ 
reading frame, thus making the cells unable to produce -galactosidase. These cells form only 
white colonies on blue-gal containing agar (Figure 3A) [35]. The recombinant bacmids are 
then isolated and validated with PCR (Figure 3B) before transfection. 
Common insect cell strains selected for Baculovirus propagation are Sf9 or Sf21 cells derived 
from the pupal ovarian tissue of Spodoptera frugiperda worm and High-Five™ cells from 
cabbage looper [34]. They can be grown either as suspension cells or adherent cells at 27°C. 
Transfection of recombinant bacmid by transfecting agents like cellfectin induced the insect 
cells to produce baculovirus that express the heterologous gene. After 72 hours of infection, 
the insect cells will lysed, releasing viruses into the media, which is known as P0 virus stock. 
The P0 virus stock is used for subsequent infection and propagation to P1 and P2 viruses for 
large-scale (volume) protein production.  
 
Figure 3: (A) Blue white colony screening after DH10Bac transposition. (B) PCR validation of white colonies 
extracted plasmids to verify the size of transposed gene of interest.  
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3.1.2.1 SMPDL3a protein expression 
The gene that encodes SMPDL3a was cloned into pFastBac-Sec vector. This vector includes 
a secretory signal peptide in order to express target gene as a secreted protein with an N-
terminal cleavable His tag for affinity purification. Bacmid carrying SMPDL3a gene is 
transfected in Sf9 cells for protein expression. Since SMPDL3a is produced as a secreted 
protein, the supernatant was collected for subsequent protein purification. 
The baculovirus insect cell system is especially beneficial for SMPDL3a protein as it requires 
post-translational modification like N-linked glycosylation. However insect cells are 
incapable of complex glycosylation as they are able to form only simple oligo-mannose sugar 
chain [36]. This may affect the biological function of the enzyme if complex glycans are 
essential for its in vivo activity.  
3.1.3 Protein purification 
After protein over-expression, proper purification is necessary and critical for structural 
studies to ensure that the protein is soluble (except for solid-state NMR), pure, homogenous, 
and in good amount for structural characterization. This is usually achieved by 
chromatography where the protein is separated based on selective binding, isoelectric point, 
hydrophobicity or size.  
3.1.3.1 Affinity tag purification 
Affinity chromatography is a common and effective method to separate target protein from 
protein mixture based on selective interaction with a ligand. The ligand that is specific 
towards target protein is coated on a stationery phase and will bind primarily to the target 
protein when a protein mixture (mobile phase) is passed through. Proteins expressed with the 
hexa-histidine fusion tag have high affinity towards nickel beads and this strategy is often 
used for initial purification of recombinant proteins. A nickel-NTA beads slurry packed in a 
column can act as the stationery phase to selectively bind the His-tagged protein. Proteins that 
do not bind specifically to the Ni-NTA will flow through the column upon washing. His-
tagged protein can be recovered by increasing the imidazole concentration or by altering the 
pH of the washing buffer (mobile phase). Imidazole can compete for interactions with nickel 
NTA while changing the pH alters the protonation state of imidazole nitrogen on histidine 
(pKa = 6.0) and disrupts the histidine-nickel interaction.  
Both L-PGDS and SMPDL3a were expressed with His-tag fusions but purified in a slightly 
different manner. As L-PGDS protein is expressed in bacteria cells, it is necessary to lyse the 
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bacteria cell wall by sonication and/or other disruption methods to extract the protein before 
chromatography. Meanwhile SMPDL3a was secreted into the media, hence no cell lysis was 
required. The media containing target protein was collected for purification. However, since 
the histidine-nickel interaction is sensitive to pH, media was first titrated with Tris pH 8 
buffer to adjust the slightly acidic pH to a neutral pH. After affinity purification, SMPDL3a 
was proteolysed by Tobacco Etch Virus (TEV) to remove the His-tag. In some cases, host 
proteins that are rich in histidines can be isolated together with the target protein. Hence, a 
second step of chromatography is required to ensure the purity. 
3.1.3.2 Size exclusion chromatography (SEC) 
This method separates molecules in solution by size (molecular weight). In this case the 
stationary phase consists of inert porous matrix that retards smaller proteins while allowing 
larger proteins to flow through, separating the mixture in an isocratic manner. Both L-PGDS 
and SMPDL3a were subjected to size exclusion chromatography. An interesting observation 
was that L-PGDS protein elution fractions appearred yellow but the color reduced with 
increasing elution time. The yellow fraction and colorless fractions were separated for 
crystallization and NMR experiments initially. No crystals were formed from the yellow 
fraction and it gave poor NMR spectra (detailed discussion in Section 3.6.2) hence only the 
colorless fractions of L-PGDS were pooled and used for all subsequent crystallization and 
NMR measurements.  
3.2 THERMAL STABILITY ASSAY  
3.2.1 Thermal aggregation method 
All proteins are stable within a specific pH and 
temperature range where its structural integrity 
is preserved to allow it to perform its function. 
Thermal induced denaturation of proteins has 
been a vital tool to access protein conformation 
stability. Binding of ligands such as co-factors, 
effectors, products or inhibitors often increase 
protein stability, but sometimes decrease 
stability (Figure 4). Ligands that induced 
significant stabilization have been shown to 
increase the probability of forming protein-
 
 
Figure 4: Protein stabilization curve in the presence and 
absence of ligands.  
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ligand complexes in crystal structures [37, 38]. Measurement of protein thermal stability can 
be done in a various ways [37, 39]. Differential scanning fluorometry that adopts SYPRO 
orange dye to bind to hydrophobic core of protein upon unfolding is not suitable for proteins 
with hydrophobic patches like L-PGDS. Therefore, in Paper I, a Harbinger Technology, 
Stargazer-384™ instrument is employed, it uses the concept that when heat denatured 
proteins are unfold they often aggregate and these aggregates can be detected by light 
scattering. This approach constitutes a convenient and high-throughput method to screen for 
ligands and compounds suitable for protein stabilization and ligand binding. The stargazer 
method is used to investigate whether different compounds were ligands for purified L-PGDS 
and as a guide for strategizing complexes generation for crystallographic studies. Substrate 
analog (SA U44069) was shown to give strongest stabilization and thus was used for the co-
crystallization experiments that eventually gave the enzyme-SA complex structure.  
3.2.2 Dot-blot method 
The stargazer method requires relatively high concentrations of proteins and it has a 
maximum temperature detection of about 80°C. Modified detection method based on similar 
principle that has been discussed in Section 3.2.1 can be used to determine thermal stability of 
protein that are less soluble or with aggregation temperature above 80°C. Instead of 
monitoring the aggregated proteins, the remaining soluble proteins are detected in a dot-blot 
after a centrifugation or filtration step. In practice, the protein sample is heated in a PCR 
iCycler followed by high-speed centrifugation to pellet aggregated protein. Aliquots of 
supernatant from each temperature point can be taken for SDS PAGE analysis (Figure 5). In 
order to facilitate large sample size analysis, aliquots are dotted on nitrocellulous membrane 
instead and subsequently probed with a protein-specific antibody, or in the case of His-tagged 
SMPDL3a, a His-probe antibody (Figure 5). Relative intensity of coomassie stained band or 
Western blot signal is measured by ImageJ/ImageLab software. Normalized relative intensity 
is plotted against each temperature point and fitted with non-linear regression in Graphpad. 
This was useful for the analysis of SMPDL3a where its native aggregation temperature is 
approximately 80°C and further stabilization by ligands and metals was not possible to be 
measured by Stargazer instrument at these high temperatures. 
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3.3 ISOTHERMAL TITRATION CALORIMETRY (ITC) 
Isothermal titration calorimetry (ITC) can be utilized to characterize the thermodynamics of 
enzyme-ligand binding interactions. Since chemical reactions and binding is accompanied by 
change in enthalpy, measuring the heat released (exothermic) or gained (endothermic) during 
enzymatic reaction can be correlated to the rate of the reaction [40]. In the case where non-
substrate ligand is supplied to the system, ITC can measure the affinity and thermodynamic 
parameters for binding instead. The experiment setup of MicroCal iTC200 consists of a 
reference cell for water, a sample cell for protein sample and a syringe for titrant. A series of 
incremental injections of the titrant are made within specific time intervals throughout the 
course of the titration experiment. For each injection, the change of enthalpy is measured and 
plotted against the concentration of ligands introduced into the protein system. Binding 
affinity and occupancy of ligand(s) can subsequently be determined. Due to the high 
reactivity of L-PGDS substrate, PGH2, it is challenging to measure the binding affinity of 
enzyme-substrate. Therefore the more stable product, PGD2 was used as a titrant in the study.  
 
 
 
Figure 5: Cartoon description of thermal stability assay for protein SMPDL3a. 
Heat 
Centrifuge 
Dot blot SDS-PAGE 
Temperature 
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3.4 MULTI-ANGLE LIGHT SCATTERING (MALS) 
Multi angle light scattering uses the principle of Rayleigh scattering to assess protein 
homogeneity, molar mass and oligomerization state. Polarizable macromolecules in solution 
are able to scatter light. The intensity of scattered light is proportional to the concentration of 
macromolecules and it is enhanced when oligomer is present because oligomer contributes to 
scattering in coherent phase. Wyatt Technology MALS system is coupled with a size 
exclusion column (Superdex 200 5/150 GL) and consists of three detectors: absorbance detector 
(UV), a static light scattering detector and a refractive index detector. MALS was used to 
determine to oligomeric state of SMPDL3a and the experiment revealed a monodisperse peak 
revealing that SMPDL3a exists as a monomer in solution (Figure 6). 
 
 
 
 
 
 
 
 
 
 
Figure 6: MALS profile for SMPDL3a protein in 20 mM HEPES pH7.5, 300 mM NaCl and 10% glycerol. 
Sample is monomeric and homogeneous eluting at mass 50.6 g/mol. 
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3.5 MACROMOLECULAR X-RAY CRYSTALLOGRAPHY   
As discussed above, X-ray crystallography is the most commonly used method for 
elucidating molecular structure of nucleic acid and proteins. The foundation of the method is 
based on the scattering property of light whereby diffraction of radiation with wavelength in 
atomic range can resolve atomic structures of macromolecules, if X-ray radiation of 
sufficiently low wavelength is used, typically in the order of 0.1 nm. In 1913, W.L. Bragg 
and W.H. Bragg proposed Braggs’s Law to describe the scattering properties of X-rays when 
they encounter atoms organized in an ordered lattice (crystal). This phenomenon termed X-
ray diffraction can be used to determine the atomic structure of the molecule(s) in the ordered 
crystal.  
3.5.1 Principles of X-ray diffraction 
Bragg’s Law states that when two in-phase X-rays incident beams are scattered by atoms that 
are separated by constant distance d in a crystal lattice, the path differences between the two 
waves is 2dsin [41] (Figure 7). This constructive interference of two scattering waves 
reflected by the consecutive lattice plane will produce an intense peak when measured with 
an X-ray detector. 
Bragg’s Law provides the location of diffraction peaks corresponding to the atom 
arrangement but measurements of the diffraction peaks’ intensities are required to calculate 
the electron density distribution in order to construct the protein structure.  The following 
Fourier transform describes how this electron density distribution relates to the strength of the 
diffraction peak.  
     

 
   
F (hkl) is referred as structure factor and the reverse Fourier transform of the above equation 
allows for the calculation of the electron density distribution in a unit cell, 
 
Figure 7: Depiction of Braggs Law. 
n = 2d sin 
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and, 
      
The structure factor amplitude |F(hkl)| can be measured directly from the intensities of 
diffraction peaks but the phase  has to be obtained indirectly. The later is done either by 
additional experiments where site specific distortions are generated in the structure leading to 
small changes in diffraction intensities, or by using a homologues structure to generate initial 
phase information. When the electron density map is of sufficient quality, the atomic 
modeling of the molecule(s) in the unit cell can be constructed and refined. A unit cell can 
house one or more molecule(s) depending on how the crystal is packed and it is the smallest 
repeating unit in a crystal. 
3.5.2 Protein crystallization 
A key challenge in macromolecule crystallography is to crystallize the subject of study, 
which may be proteins, nucleic acids or protein-ligand complexes [42]. In order to drive 
macromolecules to form crystals, a common method used is vapor diffusion. In this method, 
a small drop of highly concentrated soluble and pure protein solution is mixed with a 
precipitant in a specific ratio, placed next to a volume of precipitant reservoir in a sealed 
environment. The difference of vapor pressure between the droplet and precipitant reservoir 
will gradually drive the droplet concentration to achieve equilibrium in the closed 
environment. If the condition is optimal, this allows the protein solution to enter 
supersaturation phase and subsequently undergoes nucleation that will lead to crystal 
formation [42].  
There are many variables that could affect crystal formation [43]. Firstly, the quality of 
protein is very important. Proteins that are soluble, homogenous and stable (above 
crystallization temperature) have a higher propensity to form crystals. Other factors to be 
considered include temperature, pH, precipitant choice, precipitant concentration, precipitant-
protein ratio, presence of additive or ligands starting protein concentration, etc. The choice of 
precipitant and buffer composition is usually made by trial and error. Nowadays, 
commercially available crystallization screens are used as an initial setup of crystallization 
trials. Once the initial crystallization conditions are identified, subsequent optimization by 
altering the variables described above can further improve the quality of the crystals.  
3.5.2.1 Crystallization of L-PGDS 
L-PGDS was crystallized in the presence 2 mM substrate analog 9,11-epoxymethano PGH2 
(SA-U44069) but no crystals were formed in the absence of SA-U44069 (Figure 8A). In 
order to study the structural differences of L-PGDS with and without SA-U44069, an 
apoenzyme structure was needed. Microcrystals of L-PGDS and SA-U44069 complex (SAC) 
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were streaked on protein-precipitant drop without substrate analog. This is known as seeding 
and commonly used in protein crystallization to provide nucleation sites for molecules to 
assemble under the right condition. Crystal grown from the seed usually adopts the 
characteristics of the template crystals.  
3.5.2.2 Crystallization of SMPDL3a 
SMPDL3a, with 21.6 mg/ml concentration, took 21 days to form crystals at 24°C. Initial 
crystals were small and diffracted to 3-3.5 Å resolution (Figure 8B). The optimizations of 
crystallization condition include changing the additive concentration and temperature of 
incubation helped to reduce the period of crystal formation down to 7 days and improved the 
diffraction to 2.3 Å resolution (Figure 8C). This was sufficient for heavy atom based phasing 
experiments that were used to solve the structure.  
3.5.3 Data collection 
Once a crystal is obtained of a macromolecule, it is subjected to a focused monochromatic X-
ray beam and if it diffracts, the diffraction data can be detected and collected. The basic setup 
used nowadays has the crystal mounted in a drop containing a cryo-protectant like glycerol, 
sitting in a cryo loop and frozen under a stream of liquid nitrogen gas. The maintenance of 
the crystal at cryo temperatures often dramatically increases crystal lift time and data quality. 
An X-ray beam from a copper source is directed onto the crystal loop mounted on a 
goniometer that can be rotated in almost any orientation with respect to the beam. A detector 
then collects the diffraction spots from the rotating crystal (Figure 8D). The intensities of the 
spots, also known as reflections, can now be integrated to generate a diffraction dataset.   
 
Figure 8. (A) L-PGDS crystal after optimization (B) SMPDL3a crystals without additive (C) SMPDL3a 
crystal with 0.1M TCEP as additive (D) Basic setup of a synchrotron beamline where the sample is 
mounted on a goniometer cooled with nitrogen gas stream. When subjected to an X-ray beam, the 
diffraction pattern is collected on the detector. 
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X rays can be generated by X-ray tubes, rotating anodes or a synchrotron radiation sources. 
The synchrotron radiation is where the most powerful and highest-quality X-ray source 
available. Complete datasets can be collected within minutes at high-end synchrotron 
stations. Besides, it can produce monochromatic X-ray beam at selected wavelength that is 
useful for experimental phasing (Section 3.5.4.2).  
Dataset collections for L-PGDS and SMPDL3a have been carried out at the following 
synchrotron facilities; Australia Synchrotron (Melbourne, Australia), BESSY Helmholtz-
Zentrum (Berlin, Germany), Diamond Light Source (Oxford, UK), European Synchrotron 
Radiation Facility (Grenoble, France), Soleil (Gif sur Yvette, France) and National 
Synchrotron Research Radiation Center (Hsinchu, Taiwan). 
3.5.4 Solving the phase problem 
In order to solve the macromolecule structure, both reflection intensities and the phase 
information are required. This is depicted in the Fourier summation that generates the 
electron density in which each reflection from the diffracting crystal is represented by an 
amplitude and a relative phase () (Section 3.5.1). The phase information unlike the 
intensities (amplitudes) cannot be obtained directly using current instruments [44], this lack 
of phase information is commonly known as the phase problem.  
Nonetheless, several methods can be used to solve this problem. Phases can be determined 
experimentally by isomorphous replacement (single isomorphous replacement, SIR; multiple 
isomorphous replacement, MIR), anomalous scattering (single wavelength anomalous 
dispersion, SAD; multi-wavelength anomalous dispersion, MAD) or combination of both, 
SIRAS / MIRAS. On the other hand, if a related protein structure has been previously solved, 
molecular replacement can be employed. This section will discuss two specific 
methodologies in more detail.  
3.5.4.1 Molecular Replacement (Paper I) 
Molecular replacement (MR) is a method that uses the known phase information of a related 
structure to generate an initial phase estimate for crystals of a new protein. As a rule of 
thumb, it is good to have at least 25% of amino acid sequence identity between the previously 
solved structure - a “search model” and the unknown structure known as a “target molecule” 
for better chance of success [45]. Normally, the best search model shares more than 30% of 
sequence identity between the two. MR sequentially employs rotation and translation 
functions in finding the appropriate orientation and position of the search model in the 
asymmetric unit (Figure 9). If successful, approximate phases can be calculated from this 
model and when combined with the experimentally derived structure factor amplitudes of the 
target molecule’s crystals, an electron density map can be calculated for the target molecule. 
Subsequently, a model of the target molecule can be generated in this electron density, 
potential guided by the search model. Finally, this model is improved and refined in a cyclic 
process. Since mouse L-PGDS that shares 72.5% sequence identity with human L-PGDS had 
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been previously determined, it made a good search model to solve the structure of human L-
PGDS using molecular replacement. 
3.5.4.2 Single Anomalous Dispersion (SAD) (Paper II) 
Heavy atoms are rich in electrons, and contribute strong anomalous scattering when excited 
at a wavelength close to the atom’s absorption edge. Radiation is scattered with an altered 
phase due to the anomalous scattering and this altered phase is dependent on the heavy atom 
position in the unit cell. The site(s) of heavy atoms in the unit cell have to be determined to 
allow the phases to be calculated [46]. This method requires a good incorporation of heavy 
atoms into the crystal sample and an X-ray source with a tunable wavelength. One way of 
adding heavy atoms directly to the protein during protein expression is by using selenium 
modified methionine amino acids. Alternatively, heavy atoms can be incorporated into the 
protein crystals through co-crystallization or soaking. Some common choices of heavy atoms 
include Pt2+/Pt4+, Hg2+, Au3+ and Pb2+, which have strong affinity towards amino acids like 
histidines, cysteines and methionine. They could be added as their salts but also in the form 
of metalo-organic compounds. Apart from these commonly used heavy atoms, some natural 
occurring metals such as manganese, copper, iron and zinc are also suitable anomalous 
scatterers. 
SAD phasing requires data collection at the wavelength where absorption peak of the heavy 
atom is significant (f’) and anomalous differences is strong. In MAD phasing, additional 
diffraction data at the inflection wavelength (f”) and remote wavelength is included to 
maximize the dispersive difference thereby increasing the quality of the phase information. 
Ideally, all anomalous dataset collection should come from a single crystal to minimize non-
isomorphous difference. However, in practice radiation damage usually limits data quality.   
Zn2+ is found to stabilize the SMPDL3a protein significantly in the thermal shift assay. As 
Zn2+ has a strong anomalous signal (f = 3.9 electrons at its K edge), it was a primary choice 
for experimental phasing of SMPDL3a. Twelve heavy atom sites were located in one 
asymmetric unit cell based on data collected at the Zn edge (9.661 keV). Phases determined 
 
Figure 9. Illustration of rotation and translation functions applied onto mouse L-PGDS (PDB i.d.: 2CZT) as 
search model to solve the phase of target model, human L-PGDS. 
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by autoSHARP version 2.60 [47] yielded an electron density map that allows poly-alanine 
chain building in Coot [48] and subsequently a complete model construction by ARP/wARP 
version 7.5 from the poly-alanine model  (Figure 10) [49].   
3.6 SOLUTION NMR SPECTROSCOPY 
NMR spectroscopy is a powerful and sensitive tool for structural study and is extremely 
advantageous to complement work of X-ray crystallography. Solution NMR study the protein 
structure in the solution, hence no crystal is needed. NMR can also provide both qualitative 
and quantitative measurements of protein-protein or protein-ligand interactions as well as to 
investigate internal protein dynamics.  
Atoms are made of neutron, proton and electron each possessing the property of spin that 
comes in a magnitude of ½ . Only nuclei with a total non-zero spin are “visible” in NMR 
spectroscopy, such as 1H, 2H, 13C, 15N and 31P. When these nuclei are placed in the presence 
of static magnetic field (B0), the nuclei spins will act as magnetic moment and align in the 
magnetic field. Under thermodynamics equilibrium, the nuclei spins are populated in high 
and low energy levels based on a Bolztmann distribution. The energy required for the 
transition between two levels is represented as follow, where h is Planck constant and  is the 
gyromagnetic ratio of nuclei. 
   
When an energy that matches the energy difference (E) is applied in a form of radio 
frequency (RF), the nucleus absorbs the energy into a higher energy state and precesses 
opposing or perpendicular to B0 depending on the type of RF irradiation. The precession 
generates electric current in the detection coil and since magnetization will decay in time to 
its equilibrium state, the signal is also known as free induction decay (FID). FID is subjected 
to Fourier transform to produce the NMR spectrum for further analysis [50]. 
The NMR spectrum comprises of NMR lines located at specific frequency known as 
chemical shifts, . The frequency detected is a “shift” of nucleus magnetization signal from 
 
Figure 10. (A) Electron density map from SHARP. (B) Poly-alanine model built in Coot using the map as a 
guide.  
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B0 due to electron shielding of the molecule’s the chemical environment relative to the 
standard nucleus magnetization. The standard used in L-PGDS experiments is 4,4-dimethyl-
4-silapentane-1-sulfonic acid (DSS). Since  is dependent on the chemical environment of 
atoms, it is able to reflect the chemical structure of molecules studied. Usually a 
macromolecules solution NMR experiment would begin with a one-dimensional (1D) 
experiment followed by two-dimensional (2D) and subsequently three-dimensional (3D) 
experiments for backbone assignment and structural calculation. 
3.6.1 1D experiment : 1H 
Since 1H is present in all biological samples, naturally and abundantly, no isotope labeling is 
required in preparing the sample. Observation of 1H magnetization of the sample is known as 
1D experiment. However the high abundance of proton signal from buffer and solvent in the 
sample dwarfs the protein peak. Most importantly the NMR lines corresponding to protein 
are highly overlapped and difficult to be interpreted. Therefore it is common to adopt multi-
dimensional (2D and 3D) experiments involving 1H , 15N and 13C isotope labeled protein to 
selectively increase the signal sensitivity and reduce signal overlap from the protein sample. 
Nonetheless, 1D-experiment is routinely used to enable a brief qualitative overview of the 
protein secondary and tertiary structure. 1D-NMR spectra of L-PGDS showed a good spread 
of side chains nitrogen bound protons (HN) and backbone HN chemical shifts from 5.5 ppm to 
10 ppm indicating the protein is globular and consists of mainly -sheets structure (Figure 
11). 
 
3.6.2 2D experiment: Heteronuclear Single Quantum Coherence (HSQC) 
Multidimensional experiments are key to circumvent the limitations of 1D-experiments. They 
resolve overlapping NMR lines and provide further information of connectivity between the 
same or different nuclei in the molecule. They serve as a basis for chemical shifts assignment 
and structural elucidation. Two-dimensional 1H-15N heteronuclear single quantum coherence 
 
Figure 11: 1D-NMR spectra of  0.38 mM L-PGDS in 50 mM sodium phosphate pH 6.5, 20 mM 
NaCl, 2mM TCEP , 5% D2O and 0.5mM DSS  
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(HSQC) experiment involves the transfer of magnetization from 1H to its directly bonded 15N 
nuclei and back to 1H for detection (Figure 13B). 1H-15N HSQC spectrum maps the chemical 
shifts correlation between 1H (x-axis) and its directly bonded 15N (y-axis) in distribution of 
cross peaks. Since proteins are made of amino acids linked with peptide bonds, the majority 
of these cross peaks are related to the protein amide backbone. In addition, signals from the 
side chain NH bonds of tryptophan, arginine, lysine, histidine, glutamine and asparagine are 
also “visible”. However, proline is “invisible” due to its cyclic backbone. Most importantly 
the positions of these cross peaks are unique to every protein like a fingerprint, because it is 
based on the amino acids’ chemical and structural environment. Therefore it serves as a 
reference map for chemical shifts assignments in combination with data from other multi-
dimensional experiments. Other use of HSQC experiment involves protein quality inspection 
and protein-ligand interaction studies. 
3.6.2.1 Conformational analysis 
15N labeled L-PGDS is prepared in buffer 20 mM HEPES pH 6.5, 150 mM NaCl, 2mM 
TCEP, 10% D2O and 0.5 mM DSS for 1H-15N HSQC measurement. As mentioned previously  
in Section 3.1.3.2, L-PGDS elution from SEC has a yellow fraction (Fraction 1) and a 
colorless fraction (Fraction 2) . Even though both fractions appeared as single band in SDS 
PAGE analysis, their 1H-15N HSQC NMR spectra are distinctively different (Figure 12). The 
cross peaks from Fraction 2 are better resolved and higher in quantity as compared to 
Fraction 1. It is likely that these two fractions are conformational heterogeneous. Therefore 
Fraction 2 was pooled for both NMR and crystallography studies.  
3.6.2.2 Ligand titration 
In the event of ligand addition, the distribution of cross peaks will alter, as chemical shifts of 
the nuclei are sensitive to structural changes. This is known as ligand-induced chemical shifts 
perturbation (CSP). The 1H-15N HSQC experiment is able to locate ligand-binding site(s) in 
the protein of interest if its chemical shifts has been assigned. 1H -15N HSQC experiments of 
 
Figure 12: 2D-HSQC spectrum of L-PGDS Fraction 1 and Fraction 2 
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15N L-PGDS were recorded in the absence and presence of substrate analog (SA U44069) 
and product analog (PA 12415). Upon the addition of ligands, cross peaks of amino acids 
involved in binding and conformational changes can be detected (Figure 13A). Both analogs 
were titrated in concentrations of 2 mM, 3 mM and 4 mM. The CSP was measured for each 
cross peak and a threshold of 0.1 ppm was marked to distinguish between real binding and 
background perturbation [51]. It was also observed that HSQC spectrum of 15N L-PGDS with 
1 µL of substrate analog has significantly more cross peaks that are more resolved as 
compared to those without ligand (Appendix I & II). Therefore this spectrum is used as a 
reference sample for backbone assignment in order to assign as many residues as possible 
(Appendix III).   
Furthermore, in order to test the hypothesis of possible interactions between L-PGDS and 
membrane during hydrophobic substrate binding and product release, titration of the analog 
bound 15N L-PGDS complex with 3 mM dodecylphosphocholine (DPC) was carried out. 
DPC is a common detergent used as a membrane mimetics in NMR, especially in the study of 
interfacial membrane proteins [52]. It spontaneously forms micelle above its critical micelle 
concentration (c.m.c = 1.2 mM). Interaction of DPC micelles with 15N L-PGDS was observed 
by the changes in CSP and alteration of intensity for all detectable cross peaks. Apo-enzyme 
titration with DPC micelles was used as a control experiment. In order to specifically locate 
the site of ligand binding and membrane mimetic interactions, sequential assignment of L-
PGDS amide backbone was required. The backbone assignment was accomplished by several 
3D experiments that will be discussed in the next section.  
 
 
Figure 13: (A) 15N – HSQC of L-PGDS apoenzyme in red and with 2 mM substrate analog U44069 in blue. 
Residues Y149, M64 and Y107 are among the chemical shifts that showed significant perturbation in the 
presence of substrate analog. (B) The transfer of magnetization from 1H to its directly bonded 15N nuclei and 
back to 1H for detection in HSQC experiment.  
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3.6.3 3D experiments: HNCA, CBCA(CO)NH, 15N NOESY-HSQC, HNCO 
3.6.3.1 HNCA and CBCA(CO)NH 
Both HNCA and CBCA(CO)NH experiments require 13C and 15N enriched protein sample. 
The HNCA experiment transfers magnetization via J-coupling from amide proton to amide 
nitrogen and then to its own alpha carbon, Ci and previous residue Ci-1 subsequently back to 
amide proton for detection (Figure 14B). The magnetization transfer correlates to the amide 
cross peaks in 1H-15N dimension with its intra and inter-residue C in the 15N -13C dimension. 
The Ci , and Ci-1 cross peaks are viewed in strips where the signal of Ci  is usually stronger  
than  Ci-1, chemical shifts of these C would overlapped if they are adjacent residues (Figure 
14A).  
Meanwhile the CBCA(CO)NH experiment correlates the amide cross peak with its previous 
C and C residue also via J-couple magnetization transferred (Figure 14B). Together with 
HNCA, they provide sequential information of the amide cross peaks. Since the chemical 
shifts of C and C are distinguishable between amino acids due to their chemical structure, 
the identity of amino acids and its sequence can now be pieced together. 
 
 
Figure 14: (A) An assigned and connected strip of HNCA in 15N-13C dimension. (B) The magnetization 
transfer route for both HNCA and CBCA(CO) NH experiments. 
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3.6.3.2 15N (NOESY)- HSQC 
Nuclear Overhauser effect (NOE) is a phenomenon observed when NMR signal intensity of a 
nucleus is enhanced due to the effect of resonance frequency saturation of another nucleus in 
close spatial proximity. This effect provides information of intermolecular distances with the 
intensity of NOE proportional to 1/r6 where r is the distance between two nuclei (usually 
protons). Therefore, a proton-proton distance within 5Å will give a NOESY signal. A 
NOESY-HSQC experiment allows magnetization exchange between all protons via NOE and 
then transferred back to the amide proton for detection. In this case it acquires knowledge of 
structural proximity in relation to the amide proton. Therefore, together with L-PGDS crystal 
structure, NOESY conformational dependent information can be used to validate backbone 
assignment of the protein. 
3.6.3.3 HNCO with specific residue labeling 
Due to the close C C chemical shifts of residues like Leucine and Alanine, a labeling by 
residue type (LBRT) strategy was adopted to validate their assignments. This method 
required preparation of protein samples with 14N 13C-carbonyl labeled Leucine (or Alanine in 
a separate protein expression batch) in 15N M9 minimal media. HNCO experiments transfers 
magnetization from the amide proton to the preceding carbonyl C (CO). The signals select 
the 15N labeled residue that comes after 14N 13C-carbonyl labeled Leucine or Alanine in the 
sequence (Appendix IV & V). This information helps to resolve the ambiguity of assignment 
between these chemically alike residues.  
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4 PAPER I: THE STUDY OF LIPOCALIN PROSTGLANDIN 
D SYNTHASE (L-PGDS)  
4.1 L-PGDS IN EICOSANOIDS SIGNALLING  
Eicosanoids signaling is a major lipid-signaling pathway involved in acute inflammatory 
responses, nociception, platelet aggregation and immunoregulation [53].  External signal like 
stress triggers cytoplasmic phospholipase to activate membrane phosphatidylcholines lipid 
into arachidonic acid (AA) [54]. AA can be converted to prostaglandins by cyclooxygenase 
(COX), or turned into leukotrienes and lipoxins by the action of lipoxygenases (LOX). The 
product of COX, Prostaglandin H2 is a common substrate for thromboxane synthase and 
tissue-specific prostaglandin isomerases like Prostaglandin D2 synthase, Prostglandin E2 
synthase, Prostaglandin F2 synthase and Prostaglandin I2 synthase (Figure 15). Prostaglandins 
function in autocrine and paracrine manner interacting with cognate prostaglandin receptors 
on plasma membrane. These ligands controlled G-protein coupled receptor then activates 
downstream signaling either by intracellular changes in cyclic AMP (cAMP) concentration or 
Ca2+ mobilization [55].  
The work in Paper I focused on Lipocalin prostaglandin D2 synthase (L-PGDS). Two types of 
PGD2 synthase (PGDS) have been characterized based on its tissue distribution, 
hematopoietic PGDS (H-PGDS) and L-PGDS. H-PGDS is highly expressed in blood, mast 
cells and immune cells while lipocalin PGDS (L-PGDS) is mainly found in the central 
 
Figure 15: The arachidonic acid pathway. 
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nervous system, heart and reproductive organs [56]. They are distinct in overall structure, 
catalytic site and co-enzyme dependence despite catalyzing the same chemical reaction. H-
PGDS catalysis is glutathione dependent but L-PGDS catalysis involves a cysteine residue. 
L-PGDS also moonlights as lipophilic ligand transporter, binding molecules like retinoic 
acid, bilirubin and biliverdin. The enzyme catalytic mechanism of L-PGDS has been 
previously speculated based on mouse apoenzyme structure but the substrate positioning and 
product delivery is unknown. Paper I addresses substrate binding and mechanistic aspects of 
L-PGDS substrate binding, catalysis and egression.  
4.2 RESULTS SUMMARY 
L-PGDS – substrate analog complex (SAC) crystal structures showed two sites of plausible 
ligand interaction but the density for substrate analog SA U44069 is ambiguous even at 1.8 
Å. This uncertainty is confirmed by NMR titration studies with SA U44069 where the 
interaction sites coincide with what have been observed in the crystal structure. The 
hydrophobic moieties of the prostanoid substrate (PGH2) has only three sites for hydrogen 
bonding inside the substrate-binding pocket; a cyclic endoperoxide group, a hydroxyl group 
on aliphatic  chain and a carboxylate group on the acid tail. L-PGDS has a large 
hydrophobic beta barrel pocket relative to the size of the substrate. This increases the degree 
of freedom for PGH2 and SA flexible hydrophobic tails to reside in the binding pocket. 
Furthermore, SA U44069 comprises of a non-hydrolysable bicyclicpentane ring that reduces 
it’s the number of hydrophilic anchoring sites. It is possible that all these factors contribute to 
the poor ligand occupancy and discontinuous difference density (Fo-Fc) of SA U44069 in the 
crystal structure.  Modeling of SA U44069 in the active sites identified three key areas for 
interactions. First, the bicyclopentane head group can be stabilized by Phe 83 to be positioned 
facing Cys 65 for catalysis. Secondly its carboxylate tail can be anchored by polar residue 
like Tyr 107 or His 111 and lastly the aliphatic hydrophobic chain can be inserted deep into 
the barrel lined with serine and leucine residues.  
Co-crystal structures of L-PGDS also revealed important conformational changes of the  
helix when compared to the apoenzyme structure. This observation was also supported by 
NMR titration results with both SA U44069 and product analog (PA 12415) whereby cross 
peaks of residues on  helix undergo CSP due to ligand-induced binding. Furthermore, CSP 
analysis also supported the “stop-plug” conformational changes proposed by Zhou et al 
where the residues at the bottom of the beta barrel undergo measurable structural changes in 
the event of ligand binding [57]. Similar patterns of ligand-induced CSP were observed when 
the L-PGDS-PA complex was titrated with the DPC micelles. In fact, upon DPC micelles 
titration, CSP of L-PGDS-PA complex were more pronounced than those of L-PGDS-SA 
complex. The peak intensity analysis for DPC-L-PGDS-PA spectrum showed that for some 
residues, the intensity enhancement of cross peaks during initial addition of PA to an 
apoenzyme were reversed or further attenuated when DPC micelles were added to the PA-
enzyme complex. It is likely due to the reversal of PA binding upon DPC micelles titration. 
The contrasting CSP and cross peaks intensity alteration between DPC-L-PGDS-PA and 
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DPC-L-PGDS-SA experiments revealed different enzyme-ligand and enzyme-membrane 
interaction depending on the type of cargo bound. 
Enzymes are known to have developed diverse strategies in handling substrate and product of 
seemingly opposing chemical properties [58]. This cargo-dependent interaction may likely 
reflect the in-vivo transport nature of soluble L-PGDS utilized for hydrophobic enzymatic 
product delivery. After catalysis, the enzyme may release its product PGD2 into endoplasmic 
reticulum membrane with transient attachment facilitated by Trp 54 on  loop and Trp 112 
on E-F loop, and potentially undergo conformational changes on  helix and E-F loop. PGD2 
may be delivered to plasma membrane via vesicular transport and released to the extracellular 
space by multi-drug resistant transporters [59]. This would allow PGD2 to activate 
downstream signaling through cell surface receptors DP1 or CRTH2 (Figure 16) [60, 61]. All 
in all, an integrative structural biology strategy had provided a more holistic and resolved 
view of L-PGDS function, both as an enzyme and a transporter. 
 
 
 
 
 
 
Figure 16. Proposed model of L-PGDS as an enzyme and transporter in the cell. 
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5 PAPER II: UNRAVELING A NOVEL 
PHOSPHODIESTERASE IN STRUCTURE & FUNCTION 
5.1 SPHINGOMYELINASE PHOSPHODIESTERASE LIKE 3A (SMPDL3A) 
Since the published of human genome in 2001, transcriptomic and proteomic studies have 
been accelerated by the wealth of genomic information [62, 63]. Collaborative effort in 
bridging the genomics proteomics gap has been ongoing for the past fourteen years. 
Presently, there are many proteins which their function and regulation is still unknown. 
Computational driven function prediction for uncharacterized protein have gone beyond 
sequence homology to include cell distribution, phylogenetic profiles, protein’s domain 
analysis and gene position in chromosomes to provide a framework for experimentalist to 
plan their investigation [64]. Unknown enzymes can infer its function based on such 
predictions and are further grouped in respective family. Sphingomyelin phosphodiesterase 
like 3a (SMPDL3a) belongs to the aforementioned. With only a few published papers in the 
literature, it has been associated based on sequence homology and protein domain 
conservation to the function of the well-studied sphingomyelin phosphodiesterase 1 
(SMPD1) or commonly known as acid sphingomyelinase (aSMase).  
5.1.1 ASMase in sphingolipid hydrolysis 
ASMase is an enzyme in the sphingolipid pathway that cleaves the phosphodiester bond on 
sphingomyelin to yield ceramide, an important signaling sphingolipid. Ceramide can activate 
cell apoptosis, senescence or cell-cycle arrest. It can be converted further to ceramide-1-
phosphate, sphingosine or sphingosine-1-phosphate to regulate diverse cellular responses. 
ASMase together with other sphingolipid transforming enzymes are extremely important 
agents in governing the level of ceramide in the cells. Nonetheless, the structural basis for the 
function of aSMase is still unknown.  
Dysfunctional aSMase causes lysosomal accumulation of sphingomyelin, resulting in a 
metabolic disorder known as Niemann Pick disease (NPD) type A or type B. Patients 
suffering from NPD-A and B are found to possess missense mutations on their aSMase gene 
leading to the loss of function phenotype [65]. In more severe cases, these mutations are 
detrimental to the neurophysiology of patients and cause death in their early childhood.  
Unfortunately, the molecular effects of the disease causing mutations is still poorly 
understood.   
5.1.2 Calcineurin-like-phosphodiesterase family 
aSMase and SMPDL3a share significant sequence homology (31%) and highly conserved 
binuclear metal center containing phosphodiesterase domain, leading to the presumption that 
SMPDL3a operates in a similar manner. The phosphodiesterase domain scaffolds a catalytic 
dimetal site that composed of primarily histidine, aspartate and glutamate residues for metal 
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coordination [66]. This domain was first identified in the Ca2+ dependent serine/threonine 
protein phosphatase - calcineurin, therefore also known as calcineurin like phosphodiesterase 
domain. Despite structural similarities, many enzymes with this conserved domain were 
found to vary in their substrate selection ranging from phosphorylated proteins, cyclic 
nucleotides, glycerophosphoesters, sphingolipids, nucleotide phosphates and its metabolites. 
Furthermore they also have diverse metal cofactor composition including Fe2+, Mn2+, Ni2+, 
Mg2+, Zn2+, Ca2+ and combinations thereof [66]. These differences led to further sub-
classification based on substrate and cofactor dependence, having groups like purple acid 
phosphatase (PAP), sphingomyelinase, nucleotidase, cyclic phosphodiesterase, alkaline 
phosphatase and many others (Figure 17). In 2014, Traini et al showed that despite sharing 
the same catalytic domain as predicted from sequence similarity, SMPDL3a has no 
sphingomyelinase activity [31]. In a very recent study, it is reported that SMPDL3a is the key 
enzyme in activating a prodrug that targets fructose-1,6-bisphosphosphate (FBPase) for Type 
II diabetes treatment [67]. The work in paper II reported the structure of SMPDL3a, as the 
first structure of this novel sub-class of the calcineurin-like phosphodiesterase. Based on the 
structural and biochemical information, a possible mechanism that distinguished SMPDL3a 
from aSMase was proposed. 
5.2 RESULTS SUMMARY 
The crystal structure of human SMPDL3a revealed the expected calcineurin like 
metallophosphodiesterase fold with two metals coordinated by six histidines, two aspartates 
and one asparagine. These residues are conserved among the aSMase and aSMase-like 
proteins, which are distinct as compared to other metallophosphodiesterase proteins. The 
 
Figure 17. Multiple sequence alignment of SMPDL3a with other members of the calcineurin-
like-phosphodiesterase family is represented in a cladogram generated by Clustal Omega.  
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protein maintains a  motif that comprises almost equal number of  helices and  
strands with interspersed flexible loops. There are four N-acetylglucosamines observed in 
each protein. The functional role of these glycosylation sites is unknown although this 
glycosylation coat has been shown to protect the protein from thermal induced denaturation. 
The metals bound in native crystals were identified to be of Zn element based on a 
fluorescence scan. Additional Zn2+ (mM concentration) stabilized the protein significantly but 
inhibits its catalytic activity.  
This study confirmed that the substrate of recombinant SMPDL3a in vitro is ATP but not 
sphingomyelin. Furthermore it is found to be able to hydrolyze substituted nucleotides such 
as CDP-choline, ADP-ribose and CDP-ethanolamine. These modified nucleotides are known 
substrates for another calcineurin like member, Mn-dependent ADP-ribose diphosphatase 
[68]. In order to better understand the substrate binding and catalysis mechanism, the 
modified nucleotide and various ATP analogs were soaked into SMPDL3a crystals to obtain 
protein-ligand complexes. In the best complex, CMP moieties, derived from CDP-choline, 
can be modeled into the ligand density of molecule A and C.  Meanwhile only density that 
corresponds to phosphoribose was observed in molecule B (Figure 18) The CMP product is 
likely to be trapped inside the protein when the crystal was snap frozen after catalysis. 
Enzymatic assay and mass spectrometry analysis of the products confirmed that SMPDL3a 
hydrolysis of CDP-choline yields phosphocholine and CMP. The base moiety of CMP 
reveals specific interactions with the enzyme in molecule A. Meanwhile the ligands’ - 
phosphates interact with the active site’s metals, His 114 and His 152 residues in all three 
molecules of the asymmetric unit (Figure 18). Residues His 114 and His 152 are likely to 
play a key role anchoring the substrate at the metal site for catalysis, they are also conserved 
in aSMase .  
The newly available structural data of SMPDL3a can also be used as template for aSMase 
homology modeling. Strong structural and sequence conservation at the binuclear catalytic 
 
Figure 18. (A) Molecule A of the three subunits of CMP-bound SMPDL3a crystal structure showed interaction 
of CMP base with enzyme active site residues. (B) CMP in molecule C showed less electrostatic interaction of 
CMP base and enzyme. (C) Only electron density corresponding to the phosphoribose moiety is observed in 
molecule B. 
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site supports similarities in the chemical mechanism between aSMase and SMPDL3a while 
large differences in the rest of the substrate-binding site suggest that they are likely to 
catalyze different substrates. The model also allowed us to map known NPD mutations onto 
the model of aSMase to shed light on possible molecular basis of the enzyme inactivation in 
cases whereby mutated proteins are expressed and shuttled to lysozyme like the wild type 
aSMase [69].  
Overall, the structural and biochemical data provide better understanding on the function and 
catalytic mechanism of SMPDL3a. It is still early to completely rule out the 
sphingomyelinase activity of SMPDL3a based on current in vitro studies. However, other 
activities, such as hydrolysis of nucleotides, appear more likely based on the present data. 
Further work is however required for conclusive determination of the in-vivo function of 
SMPDL3a.  
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Appendix III : Backbone assignment of L-PGDS protein  
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Appendix IV : Overlay of    C  Alanine labeled sample HSQC spectrum (blue) with HNCO spectrum (red).
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Appendix  V : Overlay of    C Leucine labeled HSQC spectrum (blue) with HNCO spectrum (red).13
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